Copyright
©The Author(s) 2020.
World J Hepatol. May 27, 2020; 12(5): 207-219
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.207
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.207
Table 2 Causative agents summarized according to the histopathological pattern of injury
| Drugs | Hepatocellular (n = 18) | Cholestatic (n = 5) | Mixed (n = 14) |
| Anti-infective agents | 3 | 1 | 4 |
| Analgesics | 7 | 0 | 0 |
| Psychotropic agents | 2 | 0 | 0 |
| Antineoplastic agents | 1 | 0 | 1 |
| Antilipedemic agents | 0 | 1 | 1 |
| Immunomodulatory agents | 2 | 0 | 0 |
| Others | 0 | Antithyroid: 1; Thrombolytic: 1; Total parenteral nutrition: 1 | Triptan: 1; Antiemetic: 1; Methyldrostanolone: 1; Anti-inflammatory: 1; Antiarrythmic: 2 |
| Herbal/Dietary supplements | 3 | 0 | 3 |
- Citation: Siddique AS, Siddique O, Einstein M, Urtasun-Sotil E, Ligato S. Drug and herbal/dietary supplements-induced liver injury: A tertiary care center experience. World J Hepatol 2020; 12(5): 207-219
- URL: https://www.wjgnet.com/1948-5182/full/v12/i5/207.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i5.207